Literature DB >> 12406387

Up-regulation of production of TGF-beta and IL-4 and down-regulation of IL-6 by apoptotic human bronchial epithelial cells.

Sandra Hodge1, Greg Hodge, Robert Flower, Paul N Reynolds, Raffaele Scicchitano, Mark Holmes.   

Abstract

Human bronchial epithelial cells secrete cytokines that play a role in immune responses in the lung. However, the roles of these cytokines in regulating epithelial repair following acute lung injury are largely unknown. Responses to injury include hyperplasia of epithelial cells and squamous metaplasia. The resolution stage is characterized by discontinuation of hyperplasia. Apoptosis is considered to be the most efficient mechanism of removal of unwanted cells without causing inflammation. The presence of TGF-beta1 increases apoptosis, induces squamous metaplasia and inhibits proliferation of airway epithelial cells. Interleukin-4 increases the ability of macrophages to phagocytose epithelial cells and produce inflammatory cytokines. The purpose of this study was to investigate the hypothesis that apoptotic lung epithelial cells produce cytokines, which could act in an autocrine manner to control hyperplasia and induce squamous differentiation following acute lung injury. A bronchial epithelial cell line (16 HBE) was used as an in vitro model, to study the production of TGF-beta, IL-4 and IL-6 by lung epithelial cells undergoing apoptosis. Apoptotic and live cells were sorted on the basis of bright and negative staining with FITC-conjugated Annexin V, respectively. Intracellular IL-6, TGF-beta and IL-4 was measured using flow cytometric techniques. Electron microscopy, immunohistochemistry and ELISA were used as supportive techniques. Apoptotic cells produced significantly more TGF-beta and IL-4 (but less IL-6) than viable cells. Increased production of TGF-beta and IL-4 by epithelial cells undergoing apoptosis may contribute to the inhibition of proliferation, squamous metaplasia, and reduction of the inflammatory response in acute lung injury.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12406387     DOI: 10.1046/j.1440-1711.2002.01120.x

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  5 in total

1.  Onto-Tools, the toolkit of the modern biologist: Onto-Express, Onto-Compare, Onto-Design and Onto-Translate.

Authors:  Sorin Draghici; Purvesh Khatri; Pratik Bhavsar; Abhik Shah; Stephen A Krawetz; Michael A Tainsky
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

2.  Marked alveolar apoptosis/proliferation imbalance in end-stage emphysema.

Authors:  Fiorella Calabrese; Cinzia Giacometti; Bianca Beghe; Federico Rea; Monica Loy; Renzo Zuin; Giuseppe Marulli; Simonetta Baraldo; Marina Saetta; Marialuisa Valente
Journal:  Respir Res       Date:  2005-02-10

3.  M2 macrophage polarization modulates epithelial-mesenchymal transition in cisplatin-induced tubulointerstitial fibrosis.

Authors:  Chia-Cherng Yu; Chiang-Ting Chien; Tzu-Ching Chang
Journal:  Biomedicine (Taipei)       Date:  2016-02-10

4.  Cord Blood CD8+ T Cells Have a Natural Propensity to Express IL-4 in a Fatty Acid Metabolism and Caspase Activation-Dependent Manner.

Authors:  Yuxia Zhang; Jovana Maksimovic; Bing Huang; David Peter De Souza; Gaetano Naselli; Huan Chen; Li Zhang; Kai Weng; Hanquan Liang; Yanhui Xu; John M Wentworth; Nicholas D Huntington; Alicia Oshlack; Sitang Gong; Axel Kallies; Peter Vuillermin; Min Yang; Leonard C Harrison
Journal:  Front Immunol       Date:  2018-04-25       Impact factor: 7.561

5.  T cell-specific ablation of Fas leads to Fas ligand-mediated lymphocyte depletion and inflammatory pulmonary fibrosis.

Authors:  Zhenyue Hao; Brigitte Hampel; Hideo Yagita; Klaus Rajewsky
Journal:  J Exp Med       Date:  2004-05-17       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.